Leadership Insights and Growth Strategies with Jim Feinstein of ENT Partners 12-3-25

Summary

---

Becker Business Podcast

Leadership Insights and Growth Strategies with Jim Feinstein of ENT Partners

Host: Scott Becker
Guest: Jim Feinstein
Date: December 3, 2025

---

Episode Overview

In this episode, Scott Becker interviews Jim Feinstein, a renowned leader in healthcare private equity and physician practice management. Their conversation explores Feinstein’s core leadership philosophies, strategies for scaling practices, balancing investor and physician interests, lessons from valuation pitfalls, recruitment challenges in healthcare, and views on current industry trends such as value-based care.

---

Key Discussion Points & Insights

1. Core Leadership Lessons

Timestamps: 00:49–01:58

• Empathy and Operational Discipline:
  Jim emphasizes the importance of leading with empathy blended with operational discipline. He believes these pillars drive positive culture and accountability, regardless of market conditions:

  "An empathetic leader or leadership team typically makes decisions for the right reasons, which helps create a positive culture."
  (Jim Feinstein, 00:49)

• Ownership and Accountability:
  Disciplined delegation fosters teams that feel empowered and responsible for outcomes.

---

2. Culture and Scaling Successful Practices

Timestamps: 02:37–05:14

• Entrepreneurial Physician Partners:
  Successful, scalable practices are led by entrepreneurial physicians who align in vision and remain engaged after partnering with corporate entities.

  "The scalable successful relationship starts with the entrepreneurial physician which typically has a culture and a practice with a wider and broader depth and breadth of ancillary services..."
  (Jim Feinstein, 02:37)

• Role of Corporate Partners:
  The best growth happens when the corporate partner functions as a supportive management consultant, helping realize and execute the founder’s vision without subsuming it.

  "It’s really a collaboration between the vision of the founder and having a diverse talented team to help support that growth strategy."
  (Jim Feinstein, 04:30)

---

3. Balancing Investors and Physicians

Timestamps: 05:14–08:09

• Valuation Discipline:
  Paying the right price is foundational—overpaying leads to difficult investor relations and jeopardizes future performance.

  "Sometimes walking away from a good deal becomes a better deal because it just doesn't fit the economic model from an IRR or an ROI perspective."
  (Jim Feinstein, 05:50)

• Transparent, Proactive Communication:
  Regularly alerting investors about “potential lurking landmines or surprises” is crucial. Data-driven discussions foster trust with physicians.

  "Nobody likes surprises, especially private equity investors... I pride myself on my ability to communicate effectively and proactively."
  (Jim Feinstein, 06:58–07:10)

  For physicians:

  "Leading discussions opportunities with data makes the process go much smoother. And I think the physicians have a lot more respect for a team and or leader that come prepared with data..."
  (Jim Feinstein, 07:50)

---

4. Lessons from Overpaying & Market Realities

Timestamps: 08:09–11:07

• Pitfalls of Overpayment:
  Overvalued acquisitions often lead to persistent financial difficulties, especially in low-margin sectors.

  "Some of the best deals are the deals you just walk away from because they're too expensive."
  (Jim Feinstein, 09:00)

• Growth Must be Realistic:
  Buying a practice only makes sense if there’s real potential for growth (new services, more providers, or better margins), not just cost-cutting.

  "You're not going to cut costs to growth and we pride ourselves at our ability to grow these practices double digits every year post close."
  (Jim Feinstein, 10:13)

---

5. Physician Recruitment Challenge

Timestamps: 11:07–13:44

• Growing Difficulty Filling Rural Positions:
  Despite strong historic practices in non-metro areas, recruiting new providers to these locales is increasingly difficult—even generous incentives sometimes fail.

  "We're seeing significant signing bonuses...and still an inability to recruit into those marketplaces."
  (Jim Feinstein, 11:39)

• Market Selection Is Key:
  Selecting practices in attractive regions is now more important than ever due to these trends.

  "Choosing assets in the markets where recruiting will not be an issue is going to be ever so more important moving forward..."
  (Jim Feinstein, 12:33)

---

6. Industry Trends: Underrated and Overrated

Timestamps: 13:44–16:19

• Underrated:
  Persistent, proactive recruitment—always “lines in the water”—is crucial as labor market tightens.

• Overrated:
  Value-Based Care (VBC): Jim finds that while VBC is much discussed, it may be overemphasized in terms of practical impact and momentum, especially given hospital self-selection and payer relationships.

  "I think the focus and attention on value based care is I think losing momentum and falls into that overstatement category for me."
  (Jim Feinstein, 14:33)

  Scott agrees, questioning whether fee-for-service isn’t just as value-focused in practice.

  "I think it's an insult to those that are doing fee for service medicine that believe they're actually giving value for care."
  (Scott Becker, 16:09)

---

Notable Quotes

• On Leadership:

  "An empathetic leader or leadership team... helps create a positive culture."
  (Jim Feinstein, 00:49)

• On Scaling Practices:

  "The scalable successful relationship starts with the entrepreneurial physician..."
  (Jim Feinstein, 02:37)

• On Walking Away from Bad Deals:

  "Some of the best deals are the deals you just walk away from because they're too expensive."
  (Jim Feinstein, 09:00)

• On Recruitment Crisis:

  "It's virtually impossible. We're seeing significant signing bonuses... and still an inability to recruit into those marketplaces."
  (Jim Feinstein, 11:39)

• On Value-Based Care:

  "I think the focus and attention on value based care is... losing momentum and falls into that overstatement category for me."
  (Jim Feinstein, 14:33)

---

Memorable Moments & Speaker Dynamics

• Candid Take on Industry Buzzwords: Jim offers a refreshingly direct perspective on value-based care, sparking full agreement from Scott.
• Honest Reflection on Mistakes: Feinstein openly discusses past errors and their consequences (“making those mistakes early in my career...” (09:00)), adding relatability and credibility.
• Shared Frustration About Recruitment: Both speakers note the growing urgency of recruitment challenges and express concern for the system’s future.

---

Important Segments & Timestamps

• Leadership Core Principles: 00:49–01:58
• Scaling Practices: Common Factors: 02:37–05:14
• Investor vs. Physician Balance: 05:14–08:09
• Lessons on Valuation & Deal-Making: 08:09–11:07
• Provider Recruitment Realities: 11:07–13:44
• Overrated/Underrated Trends in Health Care: 13:44–16:19

---

Summary

This engaging, insight-rich episode provides invaluable guidance on how to lead and grow physician practices amid shifting healthcare and financial landscapes. Jim Feinstein’s blend of empathy, operational rigor, and hard-earned wisdom supplies actionable advice for leaders, investors, and anyone navigating the physician practice industry. Both host and guest maintain a frank, collegial tone, providing both practical solutions and candid critiques of industry dogma.

Transcript

[A]

This is Scott Becker with the Becker Business and the Becker Private Equity Podcast. We get a chance to visit today with a brilliant leader and operator and we're going to talk today leadership with Jim Feinstein. So we'll walk through several questions with Jim about leadership. Jim, let me ask you to take a second. Let me just start right from the get go and I'll ask you to introduce yourself as part of this. But you have led and built several different organizations through multiple different cycles. You've worked a lot in the healthcare private equity space and the physician practice space. Give us a couple leadership lessons that have stayed true for you that you think about that sort of you think about across good markets, tough markets. What are a couple of the core leadership lessons you'd share with our audience?

[B]

Sure. First and foremost, thanks for having me, Scott. Always appreciate the opportunity. I think you know, through good bad cycles. One of the pillars that has been constant is practicing empathy. And I think coupled with operational discipline, an empathetic leader or leadership team typically makes decisions for the right reasons, which helps create a positive culture. And I also believe the operational discipline stemming from the successful delegate and leverage model allows or breeds teams that hold themselves accountable. At the same time feel a sense of ownership. And so I feel regardless of the micro or macroeconomic environments, those pillars of leadership have proven to be successful regardless of the climate in the business environment.

[A]

Thank you. I love that concept. This discipline plus empathy, getting things done, plus treating people well, sort of execution, competence and empathy. I just love that take on it. Let me ask you another question. You see in companies scale, you've worked a lot in the physician practice business, but growing large practices, private equity funded. When you look at companies that have scaled well, are there common denominators that you see culturally, operationally that separate them from companies that end up getting stagnant or that plateau?

[B]

I think in the physician practice management space, choosing the right partner and what I mean by that is the entrepreneurial physician in my experience has a tendency to be a more successful relationship who has a tendency to understand, trust and support the strategy and the model within the PPMC space versus maybe physicians who are looking for a more traditional succession or transition plan versus a strategic partner, albeit both salient points are important within the healthcare ecosystem. I just feel that the scalable successful relationship starts with the entrepreneurial physician which typically has a culture and a practice with a wider and broader depth and breadth of ancillary services and typically stays on the cutting edge of technology modalities and infrastructure investments that others may have ignored or placed on the wayside.

[A]

But you do need in these growing practices someone with great drive and fierce leadership. That entrepreneurial physician, an entrepreneurial dyad leader. Talk about that for a second. That does seem a critical point in organizations actually grow and keep going versus stagnate.

[B]

Absolutely. And I think that that entrepreneurial physician will remain engaged when they bring on a corporate partner. And I think with the right relationship.

The PPMC model works really well when a the corporate partner becomes more of a management consulting relationship that is going to execute on that blueprint for growth and that operating partner where the physician typically knows the practice, the market better than the partner will, but doesn't have the time necessarily to the resources to execute. So to become successful in scaling and in executing that vision, I think it's really a collaboration between the vision of the founder and having a diverse talented team to help support that growth strategy.

[A]

Thank you. And Jim, talk a little bit about. You work really close with this whole mix of physicians, executive leaders and investors. What have you learned about what can you share with us about balancing all those stakeholders while still pushing the business forward? How do you balance the needs of the investors versus the physicians? We hear so much about deals that don't go as they should, where the investors and physicians get sideways. How do you avoid that? How do you keep things moving forward in the right way?

[B]

Yeah, it's a challenge, that's for sure. I think partly is.

Paying the right price for the right practice. Oftentimes any relationship starts with an overpayment or paying a significant premium for a practice. You know, you have a tendency from a corporate or investor perspective to be chasing. You're digging yourself out of the hole, out of the gate. Therefore, I think the diligence and the valuation process is so important that sometimes walking away from a good deal becomes a better deal because it just doesn't fit the economic model from an IRR or an ROI perspective. So I think that choosing the right partner, paying the right price and treating cash as king will help manage the investors relationship. Aside from erring on the side of over communicating and over preparation, I think the investors appreciate at least the half dozen of private equity partners that I've had over the past three decades appreciate.

Proactive communication when it comes to potential lurking landmines or surprises. Nobody likes surprises, especially private equity investors. And I think I pride myself on my trans.

And ability to communicate effectively and proactively. So that takes care of the investors to a certain extent. Obviously good performance trumps any and all communications. The bottom line of the P and L speaks for itself. But then when it comes to physicians, I think what we found over the years, physicians are very smart individuals, generally speaking and they like to make decisions that are data driven. So instead of wasting anyone's time having discussions or negotiations that may be somewhat qualitative and quantitative, I found that leading discussions opportunities with data makes the process go much smoother. And I think the physicians have a lot more respect for a team and or leader that come prepared with data to help drive the mission and or the agenda.

[A]

Thank you. And talk about the pricing issue on the front end because what happens is when a PE fund or a sponsor or sponsored company gets overexcited and ahead of their skis, and of course they're doing this often in a competitive bid environment, then they end up sometimes overpaying and when they overpay, you end up with higher amounts of debt and sometimes businesses that are not high margin businesses and you end up again always trying to play catch up. Talk about how is there any way to manage that other than just walking away, particularly in a time when the markets are very frothy. How do you manage that competing challenge of wanting to get a deal done with not wanting to get yourself in trouble from a longer term margin debt perspective?

[B]

Yeah, I think making those mistakes early in my career.

Has taught me that again, some of the best deals are the deals you just walk away from because they're too expensive. We've seen across multiple subspecialties, whether it's ophthalmology, dermatology, otolaryngology, a lot of failed processes over the last 24 to 36 months because of debt service. And that's a byproduct of.

Overpayment as one of the key variables in that equation in my opinion. And I think that it really becomes a function of the initial thesis when entering this business is how do you grow these businesses? If you're overpaying for these assets and they're remaining stagnant and or they're not showing growth required to drive down the multiple that you paid, then perhaps you didn't really take a look at is the practice able to add services, add providers, add patience or improve margins and if you can't check one or more than those boxes, then it's going to make that growth strategy significantly more difficult. And I'm not in the distressed asset business, I've been there before. But cutting costs to generate profits is a strategy that some embark upon. But you're not going to cut costs to Growth and we pride ourselves at our ability to grow these practices double digits every year post close. And that's a function of the aforementioned identifying the right practices that A have the physical plants to grow B are in markets that are attractive to recruit talent. Because I think that's one of the biggest challenges healthcare is facing now is how successful can you recruit the heir apparent, the new physicians to join these practices that are only going to become more and more difficult in less attractive secondary tertiary rural markets.

[A]

And this is so important, isn't it? Because if you can't add physicians and you've had this whole trend over the last generation of every physician and his or her spouse moving to the biggest 25 metro markets and you have these great successful practices in non metro markets. But the trick is can you recruit the next generation into those non metro markets even though you had somebody who just hit it out of the park in those non metro markets for a long time. That's it's a really hard recruitment, isn't it?

[B]

It's virtually impossible. We're seeing significant signing bonuses, compensation packages with first, second year guarantees that are reaching seven figures and still an inability to recruit into those marketplaces. I think given the supply and demand, the shrinking number of residency programs and fellowships, they have the opportunity to choose where they want to practice. And it's to your point, the top 25 are a lot more attractive. People want to practice in the Chicago's, Atlanta's, New Yorks versus the Little Rocks, with all due respect to the Little Rocks or Fargo, North Dakotas. And I think coming back to your previous question, choosing assets in the markets where recruiting will not be an issue is going to be ever so more important moving forward because I think there's a real problem that are not necessarily children, but grandchildren and their children are going to experience. I have a hard time imagining them being successful in receiving health care and certain services in certain markets because of the supply and demand imbalance.

[A]

I mean we're already seeing that now where to get a specialist of the right type. The, the bench is shallow. You need to know somebody. I mean it's already challenging in some of the metro markets. It's virtually impossible in some of the non metro markets. And I think it's going to get a lot worse. I can't even imagine, not just our grandchildren, but our generation and the next generation, let alone it's got to be fixed by some point in the future. The supply and demand is really getting out of whack and getting there quickly. I think so many Points are so right on. Jim, A couple more questions. One trend in healthcare or business that you think is underrated right now and one you think is overstated. Is there a trend that you think is underrated that people talk about enough, But I think you might have touched on it here and is there something you think is overstated or overrated? Any thoughts there?

[B]

Yeah, well, I think you know we touched on the, the recruitment. I, I don't know if it's fair to say it's underrated. But having, you know, internal and external resources with lines in the water at all times is going to be continue to be ever so important. I think what might be overstated and I don't want this. This may come across controversial, but I think to a certain extent the term value based care, a lot of debate, a lot of discussion about how it continues to evolve. I don't want to take anything away from the importance of clinical service and quality assurance and quality measures. But I think given the hospitals and health systems ability to self select services, site of service, the payers and relationship in the aforementioned, I think the focus and attention on value based care is I think losing momentum and falls into that overstatement category for me. Just because living in the private practice environment for 30 plus years, you know, we've witnessed and we experience the importance of an affiliated relationship with the hospitals. At the same time we understand the competitive DNA with employed physicians versus affiliated physicians and how the PCP networks are controlled and patient steerage can be driven to certain sites of services and you know, in network out of network payer strategies. So I think we definitely need to continue on quality measures. But I don't know if the whole VBC train is on the right track.

100%.

[A]

I mean it certainly seems like the value based care became a talking point and a pair point and a Medicare Advantage point and the capitator point, but not really a real value point. I mean it seems like just like I think if you talk to a fee for service physician who's doing something for pay and trying to get paid for it and doing it well, they think just as much they're giving value based care as someone who's getting a capitated fee or some other kind of fee and trying to pretend to manage care in some way or another too. I could not agree with that take on it more. I love that. Sorry Jim, and I don't mean to offend those people on the value based care world. I think it's, it's an insult to those that are doing fee for service medicine that believe they're actually giving value for care.

[B]

Absolutely.

[A]

In any event, Jim Feinstein with us today on the Becker Private Equity and Business Podcast. One of the great leaders of our time in the practice management world. Just a fantastic thinker and leader and executor. Jim, thank you so much for taking the time to visit with us today. I really enjoyed it, as always. Thank you so much.

[B]

Appreciate it. Thank you, Scott.